FDA Adverse Event Malfunction Summary report: N

MANGNUM REUSABLE CORE BIOPSY INSTRUMENT

MDR report key: 1974739 · Received December 28, 2010

Report

Report Number
2020394-2010-00374
Event Type
Malfunction
Date Received
December 28, 2010
Date of Event
November 30, 2010
Report Date
December 2, 2010
Manufacturer
BARD PERIPHERAL VASCULAR, INC.
Product Code
KNW
PMA / PMN Number
K934371
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORD WAS REVIEWED AND THE LOT MET ALL RELEASE CRITERIA. ALL DOCUMENTATION ASSOCIATED WITH THE MANUFACTURING AND ASSEMBLY OF THIS INSTRUMENT AND ITS COMPONENTS HAVE BEEN REVIEWED. THE REVIEW INDICATED THAT ALL PROCESSES AND SPECIFICATIONS WERE WITHIN ALLOWABLE PARAMETERS. THERE WERE NO ISSUES WITH RAW MATERIAL TESTING, MANUFACTURING PROCESS, AND QUALITY CONTROL INSPECTION, THERE WERE NO DEVIATIONS FOUND. THE DEVICE MET ALL RELEASE CRITERIA. THE DEVICE WAS RETURNED FOR EVALUATION. COMPONENT DAMAGE WAS CONFIRMED. IT WAS DETERMINED THAT THE REUSABLE DEVICE HAD BEEN CLEANED WITH A CHEMICAL THAT CAUSED COMPONENT DAMAGE TO THE SLEDS (DISTORTION) AND COCKING SLIDE. THIS DISTORTION PREVENTED THE DEVICE FROM ENERGIZING PROPERLY. THE ROOT CAUSE OF THE COMPONENT DAMAGE WAS IMPROPER DEVICE MAINTENANCE BY THE CUSTOMER. COMPONENTS, THE COCKING SLIDE AND THE MAIN SHAFT ASSEMBLY WERE REPLACED. THE DEVICE WAS CLEANED, LUBRICATED AND WILL BE RETURNED TO THE CUSTOMER.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A KIDNEY BIOPSY AS THE PRIMED DEVICE WAS BEING INSERTED THROUGH THE SKIN, THE DEVICE FIRED OFF WITHOUT THE FIRE BUTTON BEING DEPRESSED. THE DEVICE SAMPLED FATTY TISSUE, AND DID NOT CAUSE INJURY TO THE PATIENT. THE DEVICE WAS RE-ENERGIZED AND USED TO COMPLETE THE KIDNEY BIOPSY PROCEDURE SUCCESSFULLY. THERE WAS NO PATIENT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MANGNUM REUSABLE CORE BIOPSY INSTRUMENT KNW BARD PERIPHERAL VASCULAR, INC.

Patients

Seq Age Sex Outcome Treatment
1